Who would offer a good price, assuming an IPO will NOT generate the cash needed to line Geoffrey’s pockets?
Diabetes is integrated so much within the Medtronic manufacturing plants, so what happens there?
Also, the diabetes business is small in terms of revenue in this day and age and why would an investor put their money into complicated, highly competitive business model when they can invest in other companies, IPOs with higher rate of return!!!!!
@OP
Nobody.
@10s
Just short the whole damn thing. MDT stock is a dumpster fire
Here’s my thesis. Buy put options for the first 6-12 months as IPO, then call options for possibly acquisition. It will be grossly overvalued when IPO starts trading.
The diabetes spinoff is different than solventum. Solventum was spun off 3M to shield it from the massive liabilities (PFAS, ear plugs, etc) that 3M was facing. Looking to firewall off profitable businesses from the impending huge hammer of liability lawsuits.
Drawing parallels from those situations doesn’t make sense.
Dark days ahead for diabetes division.
If you are in that division, better bounce elsewhere now. They say 18 months. But timelines will be brought in much further than that
Probably blackstone which currently funds their diabetes will put an offer to buy it, and then do another big layoff sell it off to scraps
MDT is thinking about selling their Diabetes division? I didn't hear that.
Who would buy DIA? We have the worst bag of product and so little market share in the US.. Abbott doesn't need us. Maybe Insulet will want a sensor and a pump?
It's being sold off and will be acquired by someone else within 3 years. Watch. Q will for sure be getting a bunch of shares to get on that sinking ship, pretend to try and make it work, and then get bought out when it gets bought by Abbott or some other big player.
Like what is going on at Solventum, basically. Ironically a bunch of Medtronic guys loaded up into that c-suite sinking shitship now, too.
It will go the way of the Vent. Medtronic can't sell anything when all the engineering is off shore and they have no control over the IP, so what value does a company have other than it's customer base and it's engineering staff? None.
Who would buy diabetes?
The current Medtronic shareholders get to own it, they'll slice it off.
Not an IPO
Absolute joke and disgrace of a company.
Earl Bakken is rolling in his grave